JP2011527286A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527286A5
JP2011527286A5 JP2011508667A JP2011508667A JP2011527286A5 JP 2011527286 A5 JP2011527286 A5 JP 2011527286A5 JP 2011508667 A JP2011508667 A JP 2011508667A JP 2011508667 A JP2011508667 A JP 2011508667A JP 2011527286 A5 JP2011527286 A5 JP 2011527286A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
group
pain
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527286A (ja
JP5432246B2 (ja
Filing date
Publication date
Priority claimed from US12/433,978 external-priority patent/US20090281322A1/en
Application filed filed Critical
Publication of JP2011527286A publication Critical patent/JP2011527286A/ja
Publication of JP2011527286A5 publication Critical patent/JP2011527286A5/ja
Application granted granted Critical
Publication of JP5432246B2 publication Critical patent/JP5432246B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508667A 2008-05-08 2009-05-07 治療的に有効な置換ヒドロピリド［３，２，１−ｉｊ］キノリン化合物 Expired - Fee Related JP5432246B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5153308P 2008-05-08 2008-05-08
US61/051,533 2008-05-08
US12/433,978 US20090281322A1 (en) 2008-05-08 2009-05-01 THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS
US12/433,978 2009-05-01
PCT/US2009/043149 WO2009137681A1 (en) 2008-05-08 2009-05-07 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds

Publications (3)

Publication Number Publication Date
JP2011527286A JP2011527286A (ja) 2011-10-27
JP2011527286A5 true JP2011527286A5 (enExample) 2012-06-21
JP5432246B2 JP5432246B2 (ja) 2014-03-05

Family

ID=40863539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508667A Expired - Fee Related JP5432246B2 (ja) 2008-05-08 2009-05-07 治療的に有効な置換ヒドロピリド［３，２，１−ｉｊ］キノリン化合物

Country Status (10)

Country Link
US (1) US20090281322A1 (enExample)
EP (1) EP2294069B1 (enExample)
JP (1) JP5432246B2 (enExample)
CN (1) CN102089306A (enExample)
AU (1) AU2009244199B2 (enExample)
BR (1) BRPI0912534A2 (enExample)
CA (1) CA2723798A1 (enExample)
IL (1) IL209200A0 (enExample)
RU (1) RU2010149312A (enExample)
WO (1) WO2009137681A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2688593A2 (en) * 2011-03-25 2014-01-29 Allergan, Inc. S1p antagonists as adjunct ocular hypotensives
KR101691954B1 (ko) * 2016-04-26 2017-01-02 고려대학교 산학협력단 신규 n-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물
CN107369775B (zh) * 2017-07-13 2018-12-25 长春海谱润斯科技有限公司 一种有机电致发光材料及其有机发光器件
CN107492597B (zh) * 2017-08-10 2018-11-27 长春海谱润斯科技有限公司 一种顶发射有机发光器件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003214873A1 (en) * 2002-01-18 2003-09-02 Ceretek Llc Methods of treating conditions associated with an edg receptor
MXPA05002007A (es) * 2002-09-17 2005-04-28 Warner Lambert Co Piperazinas heterociclicas sustituidas para el tratamiento de la esquizofrenia.
US20040131648A1 (en) * 2002-10-24 2004-07-08 The Procter & Gamble Company Nuclear hormone receptor compounds, products and methods employing same
US20040167185A1 (en) * 2003-01-16 2004-08-26 Geetha Shankar Methods of treating conditions associated with an Edg-3 receptor
EP2298770A1 (en) * 2005-11-03 2011-03-23 ChemBridge Corporation Heterocyclic compounds as TrkA modulators
US8097644B2 (en) * 2006-03-28 2012-01-17 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist

Similar Documents

Publication Publication Date Title
CN103443098B (zh) 作为溶血磷脂酸受体的拮抗剂的化合物、组合物及其应用
JP2014533259A5 (enExample)
JP2011516477A5 (enExample)
JP2017520527A5 (enExample)
JP2016519680A5 (enExample)
RU2013130022A (ru) Новые бензиловые производные азетидина в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
JP2008526888A5 (enExample)
IL276624B1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases
JP2011527286A5 (enExample)
JP2014502979A5 (enExample)
JP2010516702A5 (enExample)
RU2013130878A (ru) Гидроксилированные производные аминотриазола в качестве агонистов рецептора alx
RU2013130020A (ru) Производные оксадиазола в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
RU2013128328A (ru) Новые фосфоновые кислоты как модуляторы рецептора s1p
JP6267003B2 (ja) ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
RU2020119228A (ru) Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи
JP2016516691A5 (enExample)
RU2010149312A (ru) ТЕРАПЕВТИЧЕСКИ ПОЛЕЗНЫЕ ЗАМЕЩЕННЫЕ ГИДРОПИРИДО [3,2,1-ij] ХИНОЛИНОВЫЕ СОЕДИНЕНИЯ
RU2013130023A (ru) Новые производные пиридина в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
JPWO2020033344A5 (enExample)
JPWO2020009248A5 (enExample)
JP6099209B2 (ja) 黄斑変性の予防または治療用の医薬組成物
RU2017111579A (ru) Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина
JP2009500397A5 (enExample)
JP6787926B2 (ja) 肺高血圧症の治療方法